BackCytoMed Therapeutics Overview

CytoMed Therapeutics Goodwill

Track CytoMed Therapeutics's goodwill ($360) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$355.00
↑ 36.54% YoYΔ $95.00 vs prior year quarter

Peer trimmed avg / median

Loading

CytoMed Therapeutics Goodwill History

Loading

CytoMed Therapeutics vs. peers: Goodwill Comparison

Loading

CytoMed Therapeutics Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

CytoMed Therapeutics (GDTC) FAQ

As of the most recent data (December 2025), GDTC shows a goodwill of $360. That compares with $260 in the prior-year period — up 36.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, GDTC's goodwill is now $360 (was $260) — a 36.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether CytoMed Therapeutics is outperforming or lagging.

Tracking GDTC's goodwill over time shows whether CytoMed Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $360 That compares with $260 in the prior-year period — up 36.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this goodwill page, Stockcircle has CytoMed Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect goodwill (currently $360) with ownership activity and broader fundamentals.